{"id":135019,"date":"2026-01-15T19:11:26","date_gmt":"2026-01-15T19:11:26","guid":{"rendered":"https:\/\/www.newsbeep.com\/us-ca\/135019\/"},"modified":"2026-01-15T19:11:26","modified_gmt":"2026-01-15T19:11:26","slug":"viromissile-appoints-michael-g-wood-as-chief-business-officer-news","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us-ca\/135019\/","title":{"rendered":"ViroMissile Appoints Michael G. Wood as Chief Business Officer | News"},"content":{"rendered":"<p>SAN DIEGO, Jan. 15, 2026 (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UgwtkM1tHkCRJPlAdEiPNkujdCYJzWttjDW_VPStD-4d2CyFnl8W2G-dc1w05TW4Rg_rjfnTRKeQ4JZTtwr9Jg==\" rel=\"nofollow noopener\" target=\"_blank\">ViroMissile<\/a>, Inc., a cancer immunotherapy company pioneering the IDOV\u2122 (Intravenously Deliverable Oncolytic Virus) platform, today announced the appointment of Michael G. Wood as Chief Business Officer. In this role, Mr. Wood will lead ViroMissile\u2019s corporate strategy, fundraising, and partnering activities as the company advances its proprietary IDOV\u2122 platform toward key clinical and strategic milestones.<\/p>\n<p>\u201cMichael has repeatedly demonstrated the ability to translate innovative science into well-structured, well-capitalized biotechnology companies,\u201d said Nanhai George Chen, PhD, Founder and Chief Executive Officer of ViroMissile. \u201cHis leadership across fundraising, building teams and business development significantly strengthens our management team as we execute on our mission to deliver systemically administered oncolytic virus therapies for patients with difficult-to-treat cancers.\u201d<\/p>\n<p>kAm|C] (@@5 3C:?8D &gt;@C6 E92? E9C66 564256D @7 6IA6C:6?46 DA2??:?8 3:@E649?@=@8J[ =2C86 A92C&gt;246FE:42= 4@&gt;A2?:6D[ :?G6DE&gt;6?E 32?&lt;:?8[ &gt;2?286&gt;6?E 4@?DF=E:?8[ 2?5 D4:6?E:7:4 C6D62C49[ H:E9 566A 6IA6CE:D6 \ud83d\ude15 4@CA@C2E6 DEC2E68J[ 7F?5C2:D:?8[ 3FD:?6DD 56G6=@A&gt;6?E[ 2?5 @A6C2E:@?2= D42=6\\FA] w6 92D A=2J65 2 &lt;6J C@=6 \ud83d\ude15 3F:=5:?8 2?5 25G2?4:?8 &gt;F=E:A=6 G6?EFC6\\324&lt;65 2?5 AF3=:4 3:@A92C&gt;246FE:42= 4@&gt;A2?:6D 7C@&gt; 62C=J 7@C&gt;2E:@? E9C@F89 4=:?:42=\\DE286 56G6=@A&gt;6?E 2?5 42A:E2= &gt;2C&lt;6ED C625:?6DD E@ DF446DD7F= 4@&gt;&gt;6C4:2= =2F?496D]k^Am<\/p>\n<p>kAm|@DE ?@E23=J[ |C] (@@5 7@F?565 ~?4@|JI %96C2A6FE:4D[ H96C6 96 D6CG65 2D r9:67 ~A6C2E:?8 ~77:46C 2?5 r9:67 u:?2?4:2= ~77:46C[ =65 E96 :?\\=:46?D:?8 @7 :ED @?4@=JE:4 :&gt;&gt;F?@E96C2AJ A=2E7@C&gt;[ C2:D65 Sfd &gt;:==:@? 24C@DD $6C:6D p 2?5 q 7:?2?4:?8D[ 2?5 D42=65 E96 4@&gt;A2?J\u2019D @A6C2E:@?D] !C6G:@FD=J[ 96 D6CG65 2D &#8216;:46 !C6D:56?E @7 r@CA@C2E6 s6G6=@A&gt;6?E 2?5 ~A6C2E:@?D 2E rC:?6E:4D !92C&gt;246FE:42=D D9@CE=J 27E6C :ED :?46AE:@?[ H96C6 96 =65 E96 4@&gt;A2?J\u2019D Sc_ &gt;:==:@? $6C:6D p 7:?2?4:?8 AC@46DD 2?5 DFAA@CE65 4C@DD@G6C 7:?2?4:?8 2?5 x!~ AC6A2C2E:@?] t2C=:6C \ud83d\ude15 9:D 42C66C[ |C] (@@5 96=5 D6?:@C 3FD:?6DD 56G6=@A&gt;6?E C@=6D 2E ~C6I:86? %96C2A6FE:4D[ H96C6 96 4@\\=65 2 S` 3:==:@? 8=@32= 4@\\56G6=@A&gt;6?E 2?5 4@&gt;&gt;6C4:2=:K2E:@? A2CE?6CD9:A H:E9 %2&lt;652[ 2?5 2E 2%JC !92C&gt;2[ DFAA@CE:?8 =2E6\\DE286 AC:G2E6 7:?2?4:?8D 2?5 4@CA@C2E6 DEC2E68J] w6 96=5 C@=6D \ud83d\ude15 D2=6D[ &gt;2C&lt;6E:?8[ 2?5 3FD:?6DD 56G6=@A&gt;6?E 2E p33&#8217;:6[ H96C6 96 96=A65 =2F?49 &gt;F=E:A=6 3=@4&lt;3FDE6C AC@5F4ED 2?5 DFAA@CE65 2 C2?86 @7 DEC2E68:4 3FD:?6DD 56G6=@A&gt;6?E :?:E:2E:G6D]k^Am<\/p>\n<p>kAm|C] (@@5 3682? 9:D 42C66C \ud83d\ude15 :?G6DE&gt;6?E 32?&lt;:?8 2E |@C82? $E2?=6J 2?5 &gt;2?286&gt;6?E 4@?DF=E:?8 2E %6?6E w62=E942C6[ 2?5 96 EC2:?65 2D 2 D4:6?E:DE 2E E96 $2=&lt; x?DE:EFE6[ E96 &amp;?:G6CD:EJ @7 r2=:7@C?:2[ q6C&lt;6=6J^w@H2C5 wF896D |65:42= x?DE:EFE6[ 2?5 E96 &amp;?:G6CD:EJ @7 r2=:7@C?:2[ $2? uC2?4:D4@] w6 9@=5D 2 q]$] \ud83d\ude15 |@=64F=2C 2?5 r6== q:@=@8J 7C@&gt; E96 &amp;?:G6CD:EJ @7 r2=:7@C?:2[ q6C&lt;6=6J[ 2?5 2? |qp 7C@&gt; E96 &amp;?:G6CD:EJ @7 r9:428@ q@@E9 $49@@= @7 qFD:?6DD]k^Am<\/p>\n<p>kAm|:4926= (@@5 25565[ \u201c&#8217;:C@|:DD:=6\u2019D 5:776C6?E:2E65 xs~&#8217;\u2122 A=2E7@C&gt; DF446DD7F==J 255C6DD6D @?6 @7 E96 &gt;@DE 7F?52&gt;6?E2= =:&gt;:E2E:@?D \ud83d\ude15 @?4@=JE:4 G:C@E96C2AJ\u2014DJDE6&gt;:4 56=:G6CJ] x\u2019&gt; E9C:==65 E@ ;@:? E96 4@&gt;A2?J[ =625 3FD:?6DD 56G6=@A&gt;6?E :?:E:2E:G6D E92E H:== 5C:G6 E96 ?6IE A92D6 @7 8C@HE9[ 2?5 96=A &#8216;:C@|:DD:=6 6DE23=:D9 @FC @?4@=JE:4 G:C@E96C2AJ 2D E96 ?6IE A:==2C @7 42?46C :&gt;&gt;F?@E96C2AJ]\u201dk^Am<\/p>\n<p>kAm|C] (@@5 ;@:?D E96 4@&gt;A2?J @? E96 966=D @7 E96 :?:E:2E:@? @7 7:CDE \ud83d\ude15 9F&gt;2? EC:2=D @7 xs~&#8217;\\:&gt;&gt;F?6[ E96 4@&gt;A2?J\u2019D A=2E7@C&gt; G:CFD[ 2??@F?465 =2DE &gt;@?E9]k^Am<\/p>\n<p>kAmp3@FE &#8216;:C@|:DD:=6[ x?4]k^Am<\/p>\n<p>kAm&#8217;:C@|:DD:=6[ x?4] \ud83d\ude00 2 42?46C :&gt;&gt;F?@E96C2AJ 4@&gt;A2?J 92C?6DD:?8 2 DJDE6&gt;:42==J 56=:G6C65 @?4@=JE:4 G:CFD E92E D66@CD E9C@F89@FE E96 3@5J] pD E96 7:CDE 4@&gt;A2?J E@ 56&gt;@?DEC2E6 67764E:G6 :?EC2G6?@FD EF&gt;@C E2C86E:?8 H:E9 2? @?4@=JE:4 G:CFD \ud83d\ude15 9F&gt;2?D[ &#8216;:C@|:DD:=6 \ud83d\ude00 =625:?8 2 ?6H 6C2 @7 G:C2= :&gt;&gt;F?@E96C2AJ E92E 4@&gt;3:?6D 5:C64E EF&gt;@C &lt;:==:?8 H:E9 :&gt;&gt;F?6 24E:G2E:@? 7@C 5FC23=6 C6DA@?D6D \ud83d\ude15 A2E:6?ED H:E9 25G2?465 D@=:5 EF&gt;@CD] %96 4@&gt;A2?J\u2019D AC@AC:6E2CJ xs~&#8217;\u2122 Wx?EC2G6?@FD=J s6=:G6C23=6 ~?4@=JE:4 &#8216;:CFDX A=2E7@C&gt; \ud83d\ude00 56D:8?65 E@ 6IE6?5 E96 C6249 @7 :&gt;&gt;F?@E96C2AJ E@ &gt;6E2DE2E:4 2?5 EC62E&gt;6?E\\C6D:DE2?E 42?46CD]k^Am<\/p>\n<p>kAm|65:2 r@?E24Eik^Am<\/p>\n<p>kAm|288:6 (9:E?6Jk^Am<\/p>\n<p>kAmk2 9C67lQ9EEADi^^HHH]8=@36?6HDH:C6]4@&gt;^%C24&lt;6Cn52E2lEIb`&#8221;!q:F&#8221;2ecK=4s&#8217;ADH\\&lt;2taf&gt;&#8221;&amp;K2taf&gt;<\/p>\n","protected":false},"excerpt":{"rendered":"SAN DIEGO, Jan. 15, 2026 (GLOBE NEWSWIRE) &#8212; ViroMissile, Inc., a cancer immunotherapy company pioneering the IDOV\u2122 (Intravenously&hellip;\n","protected":false},"author":2,"featured_media":576,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[151,153,152,387,4900,45732,68923],"class_list":{"0":"post-135019","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-bakersfield","8":"tag-bakersfield","9":"tag-bakersfield-headlines","10":"tag-bakersfield-news","11":"tag-business","12":"tag-cancer","13":"tag-preventive-care","14":"tag-tumors"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/posts\/135019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/comments?post=135019"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/posts\/135019\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/media\/576"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/media?parent=135019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/categories?post=135019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/tags?post=135019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}